Frequently asked questions

SimHealth is a clinician-informed digital health pre-pilot project exploring how structured, supervised digital support could complement care pathways for gambling-related harm.

The project is being developed with governance, safety, and realistic clinical integration as first-order requirements.

SimHealth is currently structured as a two-sided concept:

• a clinician portal designed for oversight, governance, and supervised pathway configuration; and
• a patient-facing experience designed for structured, time-appropriate support within agreed clinical boundaries.

SimHealth is currently intended for clinicians, clinical services, researchers, and institutions with an interest in behavioural addiction, supervised digital support, and early-stage pilot design.

We welcome contact from:

• addiction clinicians and multidisciplinary teams,
• researchers and trial coordinators,
• clinical services exploring supervised pilot work, and
• institutions interested in governance, safety, and feasibility discussion.

If you are a patient seeking support, please use the crisis and help resources provided elsewhere on this site.

This website does not present SimHealth as a medical device. Whether any component could later fall within medical device frameworks would depend on intended use, claims, evidence, and regulatory pathway decisions, none of which are asserted here.

The current stage is pre-pilot planning, governance-first design, and clinical dialogue.

No. SimHealth is not an emergency service. If you are in immediate danger or need urgent support, contact your local emergency number or use the crisis resources listed on this site.

The questionnaire gathers professional input to reduce assumptions and shape the pre-pilot responsibly. It focuses on what matters in practice: workflow fit, oversight expectations, real-world adoption, accessibility, and safety risks that must be mitigated before any wider use.

The questionnaire is grouped into themes:

• Professional context — helps interpret responses responsibly.
• Current tools & workflow — identifies what already works and where gaps exist (timing, visibility, burden).
• Engagement & accessibility — surfaces practical adoption factors and barriers (e.g., cognitive load, readability).
• Pilot readiness & risks — informs safety-first feasibility planning and what “good” looks like in a supervised pilot.
• Data & governance (high level) — clarifies what oversight, DPIA expectations, and incident processes organisations require.

No. Email is optional unless you explicitly consent to follow-up or project updates. If you tick an option requesting contact or updates, we ask for an email address so we can fulfil that request.

No. Please do not submit patient-identifying information or detailed case material. The questionnaire is for high-level professional feedback and feasibility planning.

Submissions are used to inform feasibility planning, governance requirements, safety considerations, accessibility decisions, and evaluation priorities for supervised pre-pilot work. If you consented to follow-up or updates and provided an email address, you may receive a confirmation message and occasional project-related communication.

We aim to keep data collection minimal and proportionate. Depending on what you enter, a submission may include:

• your questionnaire responses;
• optional contact information (name, organisation, email) if you choose to provide it;
• basic metadata like language, timestamp, and page name; and
• technical metadata (e.g., browser user-agent, referrer) for reliability and debugging.

Please do not include patient-identifying information or sensitive case details.

Questionnaire data is used for research planning and project improvement: feasibility design, safety-first governance, usability, and evaluation planning. It is not used to provide clinical advice, make diagnoses, or make automated decisions about individuals.

It can be. If you leave optional contact fields blank, your submission can be anonymous. If you provide contact details, the submission becomes identifiable.

No. SimHealth does not sell questionnaire data and does not share it with advertisers.

Data is retained only for as long as reasonably necessary for project planning, governance, and related administrative purposes, and retention practices may evolve as the project develops. If you would like your submission removed, you can request deletion at any time.

You can request deletion at any time by emailing contact@simhealth.pro.

To help locate your submission, include:

• the email address used (if you provided one),
• the approximate date and time of submission, and
• whether you used the English or French questionnaire page.

If you submitted anonymously with no identifiers, deletion may be difficult because there may be no reliable way to locate your submission. In that case, contact us and we will explain what may be possible.

Yes. You can withdraw consent for follow-up or updates by emailing contact@simhealth.pro. If unsubscribe links are provided in emails, you can also use those to stop future updates.

They are not the same:

• Project updates means you may receive occasional news, such as milestones, governance progress, or publications. This does not enrol you in any pilot or study.
• Pilot interest means you are open to a conversation about potential participation in supervised pre-pilot work. It still does not enrol you automatically. Any pilot participation would require explicit agreement and appropriate governance documentation.

No. Completing the questionnaire does not enrol you in a pilot or study. It is for professional feedback and feasibility planning.

If you opted into contact and provided an email, we may follow up to clarify context and discuss governance expectations. Any next steps would be handled through formal documentation and partner review where appropriate.

CET+ refers to a structured conceptual framework being developed for supervised digital support pathways. It is informed by established clinical ideas, including cue-exposure approaches, and is being shaped around conservative, safety-first use with clinician oversight.

This FAQ intentionally remains high-level and does not publish protocol-level detail.

ACUI stands for Adaptive Clinical User Interface. It is a design approach aimed at reducing barriers across different needs and contexts. The focus is usability and accessibility, such as reducing cognitive load, improving readability, and supporting different pacing and clarity requirements.

ACUI is not a diagnostic tool. It is a product design approach.

“Adaptive” can mean conservative adjustments such as:

• simplifying layouts and reducing visual density,
• adjusting pacing and content chunking,
• supporting contrast or readability needs,
• and respecting clinician-configured boundaries.

Any adaptive behaviour should be transparent, bounded, and aligned with governance controls.

The concept includes a patient-facing experience designed to provide structured, time-appropriate support within agreed clinical boundaries. It is intended to be supervised rather than positioned as an unsupervised consumer wellness app.

The clinician portal is designed for governance and oversight, such as configuring pathways, setting boundaries, reviewing engagement at an appropriate level, and supporting pilot documentation. Specific features are shaped through pre-pilot planning and partner feedback.

No. This site makes no outcome claims. The current focus is feasibility planning, governance, and safety-first design.

No. SimHealth is not a replacement for clinical care. The aim is to explore supervised digital support that could complement care pathways, within agreed boundaries and clinical judgement.

No. This site provides informational content about the project and its planning approach. It does not provide personalised clinical advice.

If you’re interested in governance input, feasibility discussion, or supervised pilot exploration, you can complete the questionnaire and opt into follow-up, or contact us via the Contact page.

Institutional participation commonly requires governance review and agreement on oversight, data processing arrangements where relevant, DPIA expectations, and clear incident pathways. The questionnaire helps surface what your organisation expects.